Skip to content
Search

Latest Stories

India's Reliance Industries explores bid for Walgreens' Boots business: Bloomberg News

Indian billionaire Mukesh Ambani's Reliance Industries is exploring a bid for Boots UK, Bloomberg News reported last week, citing people familiar with the matter.

Walgreens Boots Alliance is selling its UK-based Boots business as part of an auction process led by Goldman Sachs and can be valued at up to £8 billion, Reuters reported in February, citing sources.


The Boots business spans across 2,200 stores in the UK, including pharmacies, health and beauty stores, according to the chain's website.

Deliberations were ongoing and there was no certainty Reliance, one of the world’s largest multinational conglomerates and India's largest private sector company, would actually bid for Boots, the Bloomberg report quoted people who asked not to be identified as the information was confidential.

While a spokesperson for Boots declined to comment on the news, Reliance was not available for response either.

The Mumbai-headquartered Reliance Industries -- which has already acquired NetMeds, an online medicine seller -- has grown on the back of its oil and petrochemicals business. In recent years it has expanded into other sectors including retail, entertainment and telecoms.

Boots UK will be a major global investment attempt by Reliance after its unsuccessful foray into the US shale gas market.

Meanwhile, US-based Walgreens said in January it was conducting a strategic review of the Boots business as the second largest US pharmacy chain renews its focus on domestic healthcare.

A news report earlier in the month indicated that WBA could risk losing billions after a private equity firm interested in buying Boots UK valued the retailer at a steep discount.

In addition to a consortium of CVC Capital Partners and Bain Capital, other suitors for Boots include TDR Capital, which owns supermarket chain Asda, US investment firm Apollo Global Management and Sycamore Capital.

More For You

MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less
​Pope Francis

Pope Francis at the Vatican on December 4, 2024.

Photo by FILIPPO MONTEFORTE/AFP via Getty Images

His Holiness Mahant Swami Maharaj offers condolences to Catholic community following Pope Francis' passing

His Holiness Mahant Swami Maharaj, the spiritual leader and president of the Bochasanwasi Akshar Purushottam Swaminarayan Sanstha (BAPS), has expressed heartfelt condolences to the Catholic community worldwide following the passing of Pope Francis on Monday.

In a formal letter addressed to the members of the Roman Catholic Church, Mahant Swami Maharaj conveyed the deep sorrow of the BAPS Swaminarayan Hindu fellowship, acknowledging the Pope's passing as “a profound loss to the Catholic community and Christians around the world.”

Keep ReadingShow less
Pharmacies in Northern Ireland distribute free booklets to raise cancer awareness

Dr Anna Cullen, Public Health Registrar at the Public Health Agency and Clare Conroy, Community Pharmacist from Meigh Pharmacy in Co Down.

Photo credit: Community Pharmacy Northern Ireland

Pharmacies in Northern Ireland help raise cancer awareness

Community pharmacies across Northern Ireland are distributing a free information booklet to help raise public awareness of the signs and symptoms of cancer and promote early diagnosis.

The initiative is part of the ‘Be Cancer Aware’ campaign, which has been running in pharmacies since April and will continue through May as part of the Living Well service.

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less